Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More

Hologic/ACLA: Julie Khani

The American Clinical Laboratory Association said this week that President Julie Khani will depart the organization. She will be joining Hologic, where she will serve as vice president of government affairs. Khani has served as president of ACLA since January 2017. She joined ACLA in July 2013 and has also served as its senior vice president and executive vice president. Prior to ACLA, Khani was vice president, public policy, for the National Association of Chain Drug Stores. The ACLA board of directors has begun a national search for Khani's replacement.


Akoya Biosciences: Myla Lai-Goldman

Akoya Biosciences has appointed Myla Lai-Goldman to its board of directors. From 1990 to 2008, Lai-Goldman held various roles at Laboratory Corporation of America and its predecessor company, Roche Biomedical Laboratories, including executive vice president, chief medical officer, and chief scientific officer. She is currently the chair of precision medicine company GeneCentric Therapeutics, which she cofounded and for which she previously served as CEO and president. She is also a venture partner with Hatteras Venture Partners and managing partner of Personalized Science, a diagnostic consulting company that she founded in 2008. She is board certified in anatomic and clinical pathology, and received her medical degree from Columbia University College of Physicians and Surgeons.


Caris Life Sciences: Milan Radovich

Caris Life Sciences said this week that Milan Radovich has joined the firm as chief precision medicine officer. In this role, Radovich will lead Caris' biomarker and drug intelligence teams, aiming to develop novel signatures and drug targets. Before joining Caris, Radovich was an associate professor at the Indiana University School of Medicine, vice president for oncology genomics at Indiana University Health, and co-director of the IU Health Precision Genomics Program. As a National Cancer Institute-funded investigator, his research focused on the use of genomics in translational oncology, particularly on the use of genomics in clinical studies, genomically informed drug combinations, circulating biomarkers for cancer detection, and creating novel bioinformatic pipelines for cancer genome analyses.


For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.